Product Introduction

ATORNIZ-C CAP (10 Pcs) is a reliable medicine targeting various health issues in the Cardiology segment. Formulated as a convenient CAP, it provides target-specific action to resolve symptoms, support cellular recovery, and improve the patient's daily quality of life.

Uses of ATORNIZ-C CAP (10 Pcs)

• Management of hypercholesterolemia (elevated blood cholesterol levels).
• Stabilization of arterial plaques to prevent vascular blockage.
• Reduction of risk factors associated with coronary artery disease.

Benefits of ATORNIZ-C CAP (10 Pcs)

• Plaque Control: Helps stabilize arterial walls and prevents plaque rupture, minimizing stroke risk.
• Vascular Health: Enhances endothelial function and promotes overall arterial elasticity.
• Lipid Optimization: Significantly lowers low-density lipoprotein (LDL) while improving HDL profiles.

Side Effects of ATORNIZ-C CAP (10 Pcs)

Common side effects may include:

• Headache or dizziness.
• Mild digestive issues like constipation, nausea, or flatulence.
• Muscle pain or weakness (myalgia).

How to Use ATORNIZ-C CAP (10 Pcs)

• Take ATORNIZ-C CAP (10 Pcs) orally as directed by your physician.
• Swallow the tablet or capsule whole with a glass of water; do not crush or chew.
• It is usually recommended to take this medication at a fixed time each day to maintain stable blood levels.

How ATORNIZ-C CAP (10 Pcs) Works

ATORNIZ-C CAP (10 Pcs) works by inhibiting HMG-CoA reductase (the rate-limiting enzyme in cholesterol synthesis) or reducing arterial tension, which lowers LDL cholesterol production in the liver and stabilizes existing arterial blockages.

Safety Advice for ATORNIZ-C CAP (10 Pcs)

• Alcohol: Limit alcohol consumption as it can increase liver enzymes and escalate the risk of muscle damage.
• Pregnancy: Absolutely contraindicated; discontinue immediately and consult your cardiologist if pregnancy is planned.
• Lactation: Discontinue breastfeeding while on this lipid-lowering medication as safety is not established.
• Kidney & Liver: Routine blood lipid panels and liver function tests are recommended to monitor efficacy and safety.